INTRODUCTION
It has now been well established that many environmental pollutants are able to disturb the normal physiology and endocrinology of organisms. These substances, termed Endocrine Disrupting Chemicals (EDCs), have been defined as "exogenous substances that cause adverse health effects in an intact organism, or its progeny, secondary to changes in endocrine function" (OECD,1997) . Exposure of fish to EDCs has been associated with reproductive adverse effects at both individual and population level in a variety of fish species (Jobling et al., 2002; Brion et al., 2004; Nash et al., 2004; Mills and Chichester, 2005) . These substances have multiple modes of action since they can potentially act on the synthesis, secretion, transport, action and elimination of endogenous hormones (Segner et al., 2003) . To date, research has focused mainly on compounds that interfere with sex steroids receptors, particularly the estrogen receptor. However, the endocrine system may also be disrupted by environmental substances through pathways and mechanisms other than those that are ERmediated. The knowledge of critical molecular and biochemical targets of EDCs in fish is thus of a great interest.
The biosynthesis of steroid hormones represents a target for EDC action, particularly the steps catalysed by cytochrome P450-dependent enzymes (Monod et al., 1993) . In vertebrates, an essential sex-related enzyme is aromatase (P450aro). Aromatase is an enzymatic complex including a NADPH-dependent cytochrome P450 reductase and a cytochrome P450 aromatase which catalyzes the final, rate-limiting step in the conversion of androgens into estrogens (Simpson et al., 1994) . In fish, this enzyme has been shown to be mainly expressed in ovary and brain. In mammals except pig, only one gene encodes the aromatase while in several teleost fish such as zebrafish (Danio rerio), goldfish (Carassius auratus) or rainbow trout (Oncorhynchus mykiss), aromatase is encoded by two different genes : cyp19a (or cyp19A1) and cyp19b (cyp19A2) (Callard and Tchoudakova, 1997; Kishida and Callard, 2001; Dalla Valle et al., 2002) . These two distinct genes generate two structurally and functionally different aromatase proteins, CYP19A1 or P450 Aro A (AroA), and CYP19A2 or P450 Aro B (AroB) (Tchoudakova and Callard, 1998; Chiang et al., 2001a; Blazquez and Piferrer, 2004) . These genes have distinct expression patterns : the brain aromatase activity is mainly due to the expression of the cyp19b gene while the ovarian aromatase activity is mainly due to the expression of the cyp19a gene (Tchoudakova and Callard, 1998; Chiang et al., 2001b; Forlano et al., 2001; Kishida and Callard, 2001; Trant et al., 2001; Dalla Valle et al., 2002; Menuet et al., 2005) .
In teleost fish, brain aromatase activity is much higher than in mammals (Pasmanik and Callard, 1985; Pasmanik and Callard, 1988) . This very high expression of brain aromatase could be linked to the capability of fish brain to grow during adulthood (Gelinas et al., 1998; Forlano et al., 2001) . In the gonads, transcription of the aromatase gene has been proposed as a key step in the process of ovarian differentiation. For instance, in the rainbow trout (Oncorhynchus mykiss), inhibition of ovarian aromatase in undifferentiated female resulted in a complete masculinization of an all-female population (Guiguen et al., 1999) .
Moreover, during the female reproductive cycle, ovarian secretion of 17 -estradiol controls the hepatic synthesis of vitellogenin, a phospho-lipoprotein corresponding to the major precursor of embryonic trophics reserves (Flouriot et al., 1997) .
Recent studies have reported alterations of brain and/or ovarian P450 aromatase activities in wild fish collected from contaminated sites (Noaksson et al., 2001; Orlando et al., 2002; Noaksson et al., 2003; Lavado et al., 2004) suggesting that fish populations are exposed to substances that perturb the biosynthesis of estrogens. However the nature (and the levels) of substances involved in these biological responses remains to be determined. In fish, a few studies have shown that environmental chemicals can interfere with aromatase activity. In these studies, the range of substances was limited to some pesticides (Monod et al., 1993 , Noakson et al., 2003 , Ankley et al., 2005 and polycyclic aromatic hydrocarbons (PAHs) (Monteiro et al., 2000) . Thus, there is a need to provide a broader, more systematic knowledge on aromatase inhibiting potencies of environmental chemicals. Further, most of the available studies have analysed only gonadal aromatase and it remains to be determined whether the brain form is likewise affected.
Considering the critical role of aromatase in development and reproduction in fish as well as the large number of chemical substances that can potentially affect this enzyme, the aim of this study was to investigate whether several substances belonging to diverse chemical classes (pesticides, polycyclic aromatic hydrocarbon, heavy metals) affect brain and ovarian aromatase activities in rainbow trout (Oncorhynchus mykiss) in vitro. For this purpose, we first optimized a microsomal aromatase assay to measure the effect of xenobiotics on aromatase activity in fish.
MATERIALS AND METHODS

Reagents and chemicals
[1β-3H (N)]androst-4-ene-3,17-dione (specific activity 25.3 Ci / mmol) was purchased from Perkin Elmer (France) . Glucose-6-phosphate dehydrogenase was obtained from Fluka (France) . -NADPH tetrasodium salt, -NADP sodium salt, glucose-6-phosphate dipotassium salt were purchased from Sigma-Aldrich (France) . Diuron, heavy metals (triphenylarsine, cadmium chloride, and methyl mercury), PAHs (Benzo-[a]-pyrene (B[a]P) and chrysene), pentachlorophenol, 4-hydroxyandrostenedione, aminoglutethimide and clotrimazole were purchased from Sigma-Aldrich (France) . Aldrin, alpha-cypermethrin, amitrol, atrazine, benomyl, bupirimate, chlordane, difenoconazole, endosulfan, fenarimol, fenbuconazole, fipronil, heptachlor, imazalil, iprodion, isoproturon, mecoprop, methoxychlor, metolachlor, parathion-methyl, permethrin, prochloraz, propiconazole, simazine, triadimenol, trifluralin, and vinclozolin comes from Riedel-de-Haën (France) . Tri-n-butyltin chloride (TBT) was obtained from Acros Organics (France) . 2,3,7,8 TCDD was obtained from Promochem (France) , lead acetate was obtained from Rectapur (France) and 1,4,6-androstatrien-3,17-dione was obtained from Steraloïds (USA). Azimsulfuron comes from Du Pont (France) , and oxadiazon from Supelco (France) . Reagents and chemicals were of the highest purity.
Origin of fish, fish maintenance and dissections
Female rainbow trout (Oncorhynchus mykiss) were obtained from two experimental fish farms (INRA, Gournay-sur-Aronde, France and INRA, Jouy-en-Josas, France) . The fish were maintained in the laboratory under a natural photoperiod in 500 litres tanks supplied with dechlorinated tap water (temperature 15.5 +/-1.3°C, pH 8.06 +/-0.18, dissolved oxygen 8.80 +/-0.18 mg/l, conductivity 667.0 +/-6.5 µS/cm), and were fed twice a week with granules NEO prima 5 (Le gouessant aquaculture, France). Fish were killed by cranial blow, then measured and weighed. The brain and the ovaries were removed and the gonads weighed to determine the gonado-somatic index (GSI). After removal, tissues were rinsed in ice cold KCl (0.15 M). In order to obtain sufficient material for preparation of brain and gonad microsomes, brains or ovaries of fish were pooled according to their GSI and different batches of brain and ovarian microsomes were constituted such as follows : for each tissue, 4 batches of microsomes were obtained from females having GSI < 1% ("low GSI", N = 12 fish / batch), 2 other batches were obtained from females having GSI comprised between 8 % and 13 % ("medium GSI", N = 13 fish / batch) and 2 batches were obtained from females having GSI > 13 % ("high GSI", N = 17 fish / batch).
Preparation of brain and ovarian microsomes
Pooled brain or gonad tissues were homogenized with a Teflon potter homogenizer in a 50 mM potassium phosphate buffer, pH 7.4, containing 1 mM PMSF, 1 mM EDTA and 20 % glycerol (v/v) in a ratio of 1:2 (w:v). After centrifugation of the homogenates (10,000 g, 20 min, 4°C), the supernatants were collected and centrifuged at 100,000 g (90 min, 4°C). The microsomal pellet was then resuspended in the same buffer as used for the homogenisation (100 µl / fish) and the total amount of microsomal protein determined (Bradford, 1976) using BSA (Bovine Serum Albumin, Sigma-Aldrich, France) as standard. Microsomes were then aliquoted and stored at -80°C until used.
Measurement of brain and ovarian aromatase activities
Aromatase activity was determined by the tritiated water assay which measures the release of tritiated water during the conversion of [1β-3H (N)]androst-4-ene-3,17-dione to estrone (Thompson and Siiteri, 1974) . Optimal concentrations of brain and gonads microsomal proteins were determined as well as concentration of substrate, the duration and the temperature at which the enzymatic reaction occurred. The resulting assay protocol is described below. For the aromatase assay, 200 µg of brain or ovarian microsomal proteins were added to a potassium phosphate buffer (50 mM) containing a NADPH-generating system and consisting of 20 µM β-NADPH, 1 mM β-NADP, 10 mM glucose-6-phosphate, and 2 U/ml glucose-6-phosphate dehydrogenase. To assess the effect of test compounds on aromatase activity, substances were dissolved in either dimethylsulfoxide (DMSO) or ethanol Solvent concentration did not exceed 0.2 % of the final reaction mixture, i.e. 500 µl. Test compounds were incubated with microsomes during 1 hour at 27°C. The rationale for choosing 1 hour of incubation was to increase sensitivity of the aromatase assay. Indeed in a preliminary experiment, we showed that brain and ovarian IC 50 (defined as the concentration of chemical required for 50% inhibition of aromatase activity) calculated for 4-hydroxyandrostenedione were respectively 1.8 and 4.5 times lower for one hour of incubation compared to ten minutes (data not shown). After one hour at 27°C, the reaction was started by addition of 75 nM of [1β-3H (N)]androst-4-ene-3,17-dione. Appropriate controls without substrate (tissue control), cofactors, and substitution of microsomal proteins for BSA, and addition of the specific aromatase inhibitor 4-hydroxyandrostenedione at a concentration of 0.5 µM were used. After 30 min at 27°C, the reaction was stopped by the addition of 1 ml of chloroform. After extensive vortexing for 30 sec, the tubes were centrifuged at 3000 g (10 min, 4°C). The aqueous layer was removed and extracted again with 1 ml of chloroform. The aqueous layer was mixed with charcoal (5 %, w/v) to eliminate remaining organic compounds, vortexed for 30 sec and centrifuged at 4000 g (20 min, 4°C) . Then two aliquots of the supernatant (2 150 µl) were mixed with 750 µl of scintillation liquid (OptiPhase 'Hi safe' 3, Perkin Elmer, France) in two different wells of a 24-well plate (Flexibles plates 24-w, Perkin Elmer, France) and counted for 2 min in a Liquid Scintillation Counter (Microbeta, Perkin Elmer, France). As a first screening step all xenobiotics were tested at 10 µM. For IC 50 determination, all compounds were tested at concentrations between 10 nM and 100 µM except aminoglutethimide for which one concentration was added (250 µM) and androstatrienedione and 4-hydroxyandrostenedione which were tested between 0.01 nM and 1 µM.
Data analysis and statistics
The enzyme kinetic parameter (Vmax and Km) were calculated from Lineweaver-Burk inverse plots. The aromatase inhibition potency of the tested substances was expressed as IC 50 calculated using the Regtox macro for Microsoft Excel freely available at http://eric.vindimian.9online.fr/download.html REGTOX_EV7.0.5.xls (Vindimian et al., 1983) . Data were also expressed by the relative potency of aromatase inhibition (RPAI) calculated as the ratio of IC 50 value of 4-hydroxyandrostenedione to test compound.
Experimental data were expressed as mean ± standard deviation (N = 3 independent experiments performed in ducplicate). The SPSS™ software version 10.1 for Windows (SPSS, USA) was used for statistical analysis.
RESULTS
Establishment and optimisation of the microsomal aromatase assay
Subcellular localisation of the aromatase activity and specificity of the aromatase assay Aromatase activity was measured in the microsomal and cytosolic fraction of brain and gonads. In both brain and ovaries, the highest aromatase activity was located in the microsomal fraction (> 90 % in the microsomes and < 10 % in the cytosol, data not shown), which is in agreement with the subcellular localisation of the aromatase enzyme, i.e. the endoplasmic reticulum (Simpson et al., 1994) . In controls (without substrate or cofactor, substitution of microsomes for BSA or with 4 hydroxyandrostenedione), no aromatase activity was found (data not shown). All together, these experiments showed that the method is specific of the aromatization reaction.
Effect of amount of microsomal protein and time of incubation on microsomal aromatase activity
In the tritiated water assay, quantification of aromatase activity depends on degree of linearity 
Effect of substrate concentration on brain and ovarian microsomal aromatase activities : determination of affinity for androstenedione (Km) and maximum reaction rates (V max )
In order to ensure saturating concentration of substrate available for the enzyme, the effect of substrate concentration on brain and ovarian aromatase activities was assessed. In brain and ovarian microsomes, aromatase activity was maximal at 75 nM of radiolabelled androstenedione and above (Fig 2A, B) . This concentration was chosen to ensure that the substrate was not limiting.
By using the established aromatase assay, the rainbow trout aromatase affinity for androstenedione (Km) and its maximum reaction rate (V max ) were determined in both brain and ovarian microsomes (Fig 2A, B) . The Km values for androstenedione in brain and ovary were 9.9 +/-2.6 nM and 7.48 +/-1.14 respectively without significant difference. In contrast, V max were much higher in brain (V max = 453.7 +/-24.5) than in ovary (51.0 +/-1.5 fmol/mg/min) (Fig 2A, B) .
Effect of incubation temperature of microsomes on aromatase activity
Variations of the incubation temperature resulted in significant changes in aromatase activity (Fig. 3A, B) . In brain and in ovarian microsomes, aromatase activity was maximal at 18°C and 27°C respectively. At 37°C, aromatase activities in both brain and gonad were completely inhibited. In order to verify that temperature did not influence the effects of xenobiotics in the aromatase assay, microsomes were exposed to known aromatase inhibitors and incubated at 18 or 27°C. As shown by the Figure 4 , the calculated brain and ovarian IC 50 for 4-hydroxyandrostenedione and prochloraz were the same at both temperatures. Based on this data, the incubation temperature used for the microsomal assay was set at 27°C.
Brain and ovarian aromatase activities measured in the different batches of microsomes
Whatever the batch of microsomes, brain aromatase activity was systematically higher than ovarian activity (Table I) . Moreover, brain and ovarian aromatase activities were significantly different among batches : in microsomes isolated from the "high GSI" group, brain aromatase activity was significantly higher than in microsomes isolated from fish of the "low" and "medium" GSI groups. In contrast, no aromatase activity was measured in ovarian microsomes isolated from females of the "high GSI" group. From a practical point of view, the effect of environmental pollutants on brain and ovarian aromatase activities was tested on microsomes of the "medium GSI group", where both brain and ovarian aromatase activities were high.
Effect of environmental pollutants on brain and ovarian aromatase activities
Forty three environmental chemicals from different chemical classes were tested for their ability to interfere with brain and ovarian aromatase activities. As a first screening step, experiments were conducted by testing all the compounds at 10µM except for few of them which where tested at lower concentrations due to solubility limitations. The results from these experiments are summarized in Table II . Twelve out of 43 substances were potent inhibitors of aromatase activity in vitro at 10 µM both in the brain and ovaries:
androstatrienedione, 4-hydroxyandrostenedione, aminoglutethimide, clotrimazole, fenarimol, difenoconazole, fenbuconazole, imazalil, prochloraz, propiconazole, triadimenol, and methylmercury (Table II) . None of the other tested chemicals exhibited any significant effect on aromatase activity at the concentrations tested. For the active substances, dose-response experiments were then conducted to determine their IC 50 values. The results are summarised in Table III values ranging from the low to the high µM range (Table III) . Linear regression analysis
showed that there exists a significant and positive correlation between the inhibitory action of a substance on the ovarian aromatase and on the brain aromatase (R 2 = 0.85; Pearson's test, p< 0.01, Fig. 5 ). Interestingly, despite this overall correlation, tissue specific effects were highlighted for certain chemicals. For the four fungicides (clotrimazole, imazalil, prochloraz and propiconazole), no significant differences of their brain and ovarian IC 50 values were noted. In contrast, 4 out of 12 compounds (4-hydroxyandrostenedione, androstatrienedione, difenoconazole, and methylmercury) showed ovarian IC 50 values significantly lower than those measured in the brain (student's t test, p<0.05). IC 50 of aminoglutethimide and fenbuconazole were also lower than brain IC 50 but the difference was not statistically significant (Student's -t test, p = 0.06 and 0.07 respectively). Finally, triadimenol had stronger inhibitory effect on the brain than on the ovarian aromatase activity (Student's t test, p<0.05). Fenarimol had the same pattern of inhibitory effect as triadimenol but the difference was not statistically significant.
DISCUSSION
This paper describes the potential endocrine disrupting activity of xenobiotics by assessing their capacities to inhibit in vitro brain and ovarian aromatase activities of rainbow trout. We first optimized the tritiated water assay, characterized aromatase activity in the two target tissues and determined the kinetic parameters of the aromatase in brain and ovarian microsomes. Then we showed that several environmental substances are able to inhibit both brain and ovarian aromatase activities in a dose-dependent manner, indicating that they can potentially interfere with biosynthesis of endogenous estrogens and alter the androgen :
estrogen ratio. Among them, methylmercury and the triazole fungicide fenbuconazole were newly identified as in vitro inhibitors of aromatase activity in a vertebrate model.
Rainbow trout brain and ovarian microsomal aromatase assay
The tritiated water assay to measure aromatase activity has been already applied to several fish species, including goldfish (Carassius auratus) (Pasmanik and Callard, 1985) , medaka (Oryzias latipes) (Melo and Ramsdell, 2001) , perch (Perca fluviatilis) and roach (Rutilus rutilus) (Noaksson et al., 2001) , sea bass (Dicentrarchus labrax) (Gonzalez and Piferrer, 2002; Gonzalez and Piferrer, 2003) and rainbow trout (Oncorhynchus mykiss) (Monod et al., 1993; Shilling et al., 1999) . We aimed to optimize the assay in such a way that it fits to both ovarian and brain aromatase activities, and to determine whether brain and ovarian aromatase differ in their key kinetic parameters, Vmax and Km. Amount of protein, length of incubation time, and substrate concentration were found to influence aromatase activity, a finding which is in accordance with the observations of Gonzalez and Piferrer (2002) on aromatase activity in sea bass. Also temperature influenced aromatase activity. The temperature effect on aromatase activity can be associated with decreasing cyp19 mRNA expression in tilapia with increasing water temperature (D'Cotta et al., 2001; Tsai et al., 2003) . Aromatase activity of rainbow trout showed lower temperature maxima than aromatase activity of sea bass (30°C and 40°C for brain and ovary, respectively, in sea bass (Gonzalez and Piferrer, 2002) ), a difference that might be related to the fact that rainbow trout is a cold water teleost fish species while sea bass live at higher temperatures. (Gonzalez and Piferrer, 2002 ). However, it should be noted that our ovarian Km value is in disagreement with that reported by Shilling et al. (1999) for rainbow trout who found a 40-fold higher value.
Comparison of the catalytic properties
Effect of test chemicals on rainbow trout brain and ovarian aromatase activities
Aromatase activity inhibition by known aromatase inhibitors
In this study three aromatase inhibitors were used, namely two steroidal inhibitors, 4-hydroxyandrostenedione and androstatrienedione, and a non steroidal inhibitor, aminoglutethimide. Steroidal inhibitors are steroid analogues of androstenedione. They bind irreversibly to the active site of the enzyme while non steroidal inhibitor act reversibly on P450 aromatase by interacting with the heme prosthetic group of the enzyme (Brodie et al., 1986; Yue and Brodie, 1997) . The capacities of these pharmaceuticals to inhibit aromatase have been extensively studied in mammals notably within the context of estrogen-dependant cancer therapy (see Geisler and Lonning, 2005 for a review). By using different in vitro human systems (i.e., placental microsomes, human adrenocortical cells H295R, human choriocarcinoma-derived JEG3 cells), the human IC 50 values reported for these molecules ranged from 0.0015 µM to 1.5 µM for 4-hydroxyandrostenedione and from 0.0146 µM to 55 µM for aminoglutethimide (see Table III ). Our results clearly show that these compounds act as aromatase inhibitors in rainbow trout as well. That rainbow trout aromatase activity appears to be more susceptible than that of some mammalian species may reflect the high affinity of these compounds for fish aromatase (Zhao et al., 2001) . The inhibitory potency of the non steroidal aromatase inhibitor, aminoglutethimide, on brain and gonad aromatase activities of trout was much less expressed than that of the steroidal substances. This gives support to previous findings on goldfish and rainbow trout aromatase (Shilling et al., 1999; Zhao et al., 2001) . By calculating the RPAI of aminoglutethimide for human aromatase based on IC 50 data reported in different studies (Yue and Brodie, 1997; Ohno et al., 2004) , we found that aminoglutethimide was 10 to 1200-fold less effective in inhibiting rainbow trout than human aromatase. Similarly, letrozole, exhibited a 1000-fold less inhibitory potency in rainbow trout than in human (Shilling et al., 1999) . A recent study reported 53 % overall identity of the deduced amino-acid sequence of brain trout aromatase with that of human (Dalla Valle et al., 2002) . This may imply that there exist differences of tertiary structure between human and trout P450 aromatase that could explain differences in efficacy and mechanism of inhibition (Pelissero et al., 1996; Shilling et al., 1999) . The data of the present study show that there exist differences in the inhibitory potency of substances for trout and mammalian aromatase. Additionally, differences are evident between brain and gonad P450
aromatase. This underlines that although some knowledge is available for the inhibitory action of chemicals on aromatase activity in mammals, this can not be linearly extrapolated to teleostean aromatase activity.
We found that the efficacy of inhibition of ovarian aromatase by aminoglutethimide and the two steroidal inhibitors were 5 and 60 fold higher respectively comparatively to brain.
In the study of Zhao et al. (2001) it has been demonstrated that steroidal inhibitor have higher affinity for ovarian aromatase isozyme than brain aromatase in goldfish by determining the Ki. Given that rainbow trout aromatase activities in brain and ovary are supported by two structurally different proteins, i.e. P450AroA in ovary and P450AroB in brain (Dalla Valle et al., 2002) , it is possible that the differences in the amino-acid sequences of rainbow trout aromatase isozymes account for distinct response to aromatase inhibitors (IC 50 values) as previously suggested for goldfish aromatases (Zhao et al., 2001) .
Aromatase Inhibition by environmental substances
Among the environmental substances tested in this study, nine inhibited brain and ovarian aromatase activities in a dose-dependent manner among which were seven triazole and imidazole fungicides. Due to their well described capacity to inhibit sterol 14--demethylase which catalyses the synthesis of ergosterol, an essential membrane component in yeast and fungi, azole fungicides are widely used as antimycotic agents in agriculture and in human and veterinary therapies (Zarn et al., 2003) . Various imidazole-like compounds have been shown to inhibit aromatase in human placenta microsomes, and in different cell lines expressing aromatase Ayub and Levell, 1990; Vinggaard et al., 2000; Andersen et al., 2002; Sanderson et al., 2002; Ohno et al., 2004) . In fish, data are more scarce. Previous studies reported that some imidazole fungicides (clotrimazole, prochloraz, imazalil) are able to inhibit aromatase activity in fish (Monod et al., 1993; Noaksson et al., 2003; Ankley et al., 2005) . Our results confirm the capability of these imidazole fungicides to inhibit ovarian and also brain aromatase activities and extend the findings to other imidazolelike compounds. We found that clotrimazole was the most potent aromatase inhibitor of in vitro aromatase activity, both in brain and ovary, among all the tested imidazole-like compounds. This is similar to the results of Monod et al. (1993) who found that this substance was a much more potent ovarian aromatase inhibitor than prochloraz and imazalil (see Table   III ). In a cyprinid fish species, the roach (Rutilus rutilus), clotrimazole has also been shown to inhibit in vitro brain aromatase activity with an IC 50 of 0.9 µM (Noaksson et al., 2003) . Brain and ovarian IC 50 values obtained in the present study for clotrimazole were lower than those observed previously (Monod et al., 1993; Noaksson et al., 2003) which is probably due to the use of optimized assay conditions and the resulting enhanced sensitivity of the assay. Besides, species difference cannot be ruled out since the highest IC 50 value for clotrimazole was reported for the roach. This hypothesis is further supported by the very low degree of inhibition of aromatase by fenarimol in the fathead minnow compared to rainbow trout (Ankley et al., 2005) . Nevertheless, IC 50 values for prochloraz reported for the fathead minnow by Ankley et al. (2005) are similar to those reported in trout (Monod et al., 1993) .
Whether there exists species difference in sensitivity of aromatase remains to be determined.
Among the imidazole-like compounds tested in this study, only benomyl and amitrol had no effect on aromatase activity. The absence of an inhibitory effect of these two molecules is likely due to their chemical structures. Although relationship between the structure and the biological activity as inhibitors of aromatase is not simple (Sanderson et al., 2002) , it has been shown that both molecules containing an imidazole ring fused to a benzene ring (e.g. benomyl) and molecules containing an imidazole ring without aromatic ring on the N-1 substituent (e.g. amitrol) are very weak inhibitors of human aromatase (Ayub and Levell, 1988) . Therefore, our results strongly suggest that this type of structure activity described for human aromatase is also true for rainbow trout brain and ovarian aromatase.
Among the other substances tested, only methylmercury inhibited brain and ovarian aromatase activities in a dose-dependent manner. The ability of this substance to inhibit vertebrate aromatase has not been described before and the mechanism of inhibition remains to be determined. Molecules such as TBT, lead, TCDD, B[a]P, chrysene, atrazine, simazine, or vinclozoline are known to perturb aromatase expression in vitro in different cell systems (Letcher et al., 1999; Monteiro et al., 2000; Saitoh et al., 2001; Sanderson et al., 2001; Sanderson et al., 2002; Taupeau et al., 2003) but failed to produce any effect in our cell-free system. These differences rely most probably on the mechanism of action of these substances which are able of up-or down regulating the aromatase gene transcription (Saitoh et al., 2001; Sanderson et al., 2001; Sanderson et al., 2002; Taupeau et al., 2003) .
The in vitro microsomal aromatase assay is limited to measuring the inhibitory effects of the test compound on aromatase enzymatic activity through direct interaction with the enzymatic complex but does not provide any information on the effect of the test agent on the gene / protein machinery. Nonetheless, the aromatase assay can be used for ecotoxicological screening in order to identifying and characterising the mode of action and endocrine effects of environmental contaminants on a key steroidogenic enzyme. Since brain and ovarian Log IC 50 values were significantly and positively correlated (Fig 5) , environmental contaminants can be tested either on brain or ovarian microsomes. However, brain microsomes can be recommended since brain aromatase activities can be measured whatever the maturity of fish.
Several of the aromatase inhibiting substances found in our study are known to be present in the aquatic environment and to accumulate in fish. Methylmercury is a well-known contaminant of the aquatic food web that may adversely affect reproduction of wild population of fish (Drevnick and SandHeinrich, 2003) . In a recent survey of pharmaceuticals in aquatic environment, it has been shown that the fungicide clotrimazole was present at low concentrations (up to 33 ng/L) in some UK estuaries and rivers (Thomas and Hilton, 2004; Roberts and Thomas, 2006) . In surface water of French rivers, difenoconazole, fenbuconazole, iprodion, prochloraz and propiconazole have been measured at mean concentrations in the low ng/L range with maximal concentration of 1.75 µg/L for propiconazole (IFEN, 2001) . As a consequence, all these substances could potentially represent a risk for fish populations and may be involved in altered aromatase activity that have been observed in wild fish population inhabiting contaminated water (Noaksson et al., 2001; Orlando et al., 2002; Noaksson et al., 2003; Lavado et al., 2004; Noaksson et al., 2004; Noaksson et al., 2005; Martin-Skilton et al., 2006) . However, few studies have been conducted to assess the in vivo effect of these compounds on brain and ovarian aromatase activities in fish and it would be advisable to determine to which extent the inhibitory potency of xenobiotics on in vitro aromatase activity can be extrapolated to the in vivo situation. Our results concerning the inhibitory effect of methylmercury on brain and ovarian aromatase activities are consistent with the decreasing circulating concentrations of estradiol measured in female fathead minnow fed with methylmercury (Drevnick and Sandheinrich, 2003) .
Similarly, prochloraz in the fathead minnow caused a suite of in vivo responses consistent with inhibition of steroidogenesis, i.e. decrease of estradiol and vitellogenin synthesis in female (Ankley et al., 2005) . However, the same authors showed that the endocrine effects of fenarimol were more ambiguous with notably an increased concentration of circulating estradiol in female. Shilling et al. (1999) failed to demonstrate any effect on aromatase and vitellogenin synthesis in juvenile female rainbow trout exposed to clotrimazole. All these data suggest that extrapolation of in vitro study of xenobiotics interference with aromatase enzyme (and more generally steroidogenic enzyme) to the in vivo situation is not an easy task. It should be related to the in vivo pharmaco-toxicokinetic and the multiple mode of action of these molecules on the endocrine system as well as the complexity of the synthesis pathway (Andersen et al., 2002; Sanderson and Van den Berg, 2003; Ankley et al., 2005) . Taken together, further in vivo studies are needed.
CONCLUSION
The optimized aromatase activity assay with rainbow trout microsomes developed in this study is a suitable test for screening for aromatase inhibiting activities of environmental contaminants. The assay can distinguish inhibitory effects in the brain and the ovary, and we
show for the first time that the two tissues differ in their sensitivity to chemical inhibition.
While ovary exhibited a higher sensitivity to steroidal inhibitors as compared to brain, the sensitivity of the two aromatases to environmental substances was broadly similar indicating that brain and ovarian aromatase are relevant biochemical target of EDCs. Our study also
indicates that methylmercury and some pesticides (clotrimazole, imazalil, prochloraz, fenbuconazole, propiconazole, difenoconazole, triadimenol, and fenarimol) , that are currently used throughout the world, have the potential to interfere with the biosynthesis of endogenous estrogens. Based on these results, it can be suggested that these compounds will affect the functioning of the HPG axis and in turn sexual development and reproduction of fish.
However, further in vivo studies are needed to support these hypothesis. Lineweaver-Burk plots to determine the Vmax and the Km. 
